Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3650.00 | 3547.00 | 1.0290 | 1.0413 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3471.00 | 3547.00 | 0.9786 | 0.9693 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 3591.00 | 3547.00 | 1.0124 | 1.0177 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1344.63 | 3702.00 | 3547.00 | 1.0437 | 1.0621 |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1344.63 | 3961.00 | 3547.00 | 1.1167 | 1.1642 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 3534.00 | 3547.00 | 0.9963 | 0.9948 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1344.63 | 2331.00 | 3547.00 | 0.6572 | 0.4817 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 3940.00 | 3547.00 | 1.1108 | 1.1560 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1344.63 | 4127.00 | 3547.00 | 1.1635 | 1.2286 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3836.00 | 3547.00 | 1.0815 | 1.1151 | |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1344.63 | 1187.00 | 3547.00 | 0.3347 | -0.0852 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 4311.00 | 3547.00 | 1.2154 | 1.2992 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 3808.00 | 3547.00 | 1.0736 | 1.1041 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 3835.00 | 3547.00 | 1.0812 | 1.1147 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3791.00 | 3547.00 | 1.0688 | 1.0974 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 3679.00 | 3547.00 | 1.0372 | 1.0529 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 3985.00 | 3547.00 | 1.1235 | 1.1735 |
| BT-20 | Erlotinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3504.00 | 3547.00 | 0.9879 | 0.9826 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1344.63 | 3666.00 | 3547.00 | 1.0335 | 1.0477 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 2852.00 | 3547.00 | 0.8041 | 0.7114 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 1023.00 | 3547.00 | 0.2884 | -0.1775 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3395.00 | 3547.00 | 0.9572 | 0.9384 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3340.00 | 3547.00 | 0.9416 | 0.9159 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2631.00 | 3547.00 | 0.7418 | 0.6155 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2952.00 | 3547.00 | 0.8323 | 0.7541 |